VMD: VMD allowed to delay the disclosure of financial statements

Vimedimex Medi – Pharma Joint Stock Company (HOSE: VMD) has received an official document dated July 21, 2020 by the State Securities Commission approving the delay in the disclosure of financial statements of VMD in 2020 as follows:

-          For the financial statements and reviewed  financial statements (if any), the Company must disclose them within 30 days from the end of quarter, but no more than 05 days from the day when the audit firm signs the reviewed financial statements;

For the semi-annual reviewed  financial statements, the Company must disclose them within 60 days from the end of first six months of fiscal year, but no more than 05 days from the day when the audit firm signs the reviewed financial statements. 

HOSE

>   VTSS: Resolution of Annual General Meeting 2020 (24/07/2020)

>   SDT: Financial Statement Quarter 2/2020 (holding company) (24/07/2020)

>   SD6: Financial Statement Quarter 2/2020 (24/07/2020)

>   SDT: Financial Statement Quarter 2/2020 (24/07/2020)

>   SAF: Reviewed financial statement 2020 (24/07/2020)

>   SD5: Financial Statement Quarter 2/2020 (24/07/2020)

>   PSW: Financial Statement Quarter 2/2020 (24/07/2020)

>   NDX: Financial Statement Quarter 2/2020 (24/07/2020)

>   MED: Financial Statement Quarter 2/2020 (24/07/2020)

>   D11: Financial Statement Quarter 2/2020 (24/07/2020)